Publications scientifiques

2614 PUBLICATIONS

ANNÉE

JOURNAL

PREMIER AUTEUR

TITRE

ANNÉE2026

JOURNALJournal of adolescent and young adult oncology

PREMIER AUTEURMartin S

TITREImpact of Social Media on Adolescents and Young Adults with Solid Tumors or Hematological Malignancies: A Multicenter Study.

ANNÉE2026

JOURNALCell reports. Medicine

PREMIER AUTEURGeorgievski A

TITREValrubicin-loaded immunoliposomes targeting antigens on immunosuppressive cells to circumvent resistance to cancer immunotherapy.

ANNÉE2026

JOURNALBreast cancer research and treatment

PREMIER AUTEURDrozd C

TITREEffect of a supervised intermittent exercise program on insomnia in breast cancer patients undergoing chemotherapy.

ANNÉE2026

JOURNALViruses

PREMIER AUTEURHaennel Y

TITREHepatitis D Virus Pathogenesis: A Sense of Complications.

ANNÉE2026

JOURNALJMIR cancer

PREMIER AUTEURClaessens A

TITREAI-Driven Patient Screening for Clinical Trials in Pancreatic Cancer: The PANCR-AI Pilot Retrospective Comparative Study.

ANNÉE2026

JOURNALWorld journal of surgery

PREMIER AUTEURBachellier P

TITRETransposition of an Aberrant Right Hepatic Artery on the Gastroduodenal Artery During Pancreatoduodenectomy for Cancer: Technique and Outcomes at a Specialized Vascular Pancreatic Surgery Center.

ANNÉE2026

JOURNALWorld journal of surgery

PREMIER AUTEURAddeo P

TITRETwo-Stage Hepatectomy for Bilobar Colorectal Liver Metastases: Outcomes According to Liver Transplant Selection Criteria.

ANNÉE2026

JOURNALAnnals of hematology

PREMIER AUTEURRenosi F

TITREContribution of a specific panel by flow cytometry for the differential diagnosis of plasmacytoid dendritic cell neoplasms.

ANNÉE2026

JOURNALMelanoma research

PREMIER AUTEURDevoldere A

TITREDeterminants of adjuvant treatment choice between immunotherapy (immune checkpoint inhibitor) and targeted therapy in resected stage III BRAF V600-mutated cutaneous melanoma: a multicenter observational study: MELADJ3.

ANNÉE2026

JOURNALFrontiers in immunology

PREMIER AUTEURPeroz M

TITREDeep learning-based assessment of PD-L1 expression in NSCLC predicts outcome for patients treated with anti-PD-1 immunotherapy.

Retrouvez aussi

Unités de recherche, établissements

Projets de recherche

Publications scientifiques